Merck has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks. As part of the agreement Merck must submit all new TV commercials for its drugs to the FDA for review before they can be aired. Another provision bars the company from "ghostwriting," a practice in which academic scientists were allegedly paid to take credit for positive research articles prepared by company-hired medical writers.
May 21, 2008 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Merck & Co. has agreed to pay $58 million as part of a multistate settlement of allegations that its ads for the once-popular painkiller Vioxx deceptively played down the health risks.
The agreement announced Tuesday also calls for Merck to submit all new TV commercials for its drugs to the Food and Drug Administration for review before they can be aired.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law.com celebrates the California law firms and legal departments driving the state's dynamic legal landscape.
The Texas Lawyer honors attorneys and judges who have made a remarkable difference in the legal profession in Texas.
The Superior Court of California, County of Alameda is accepting applications for the position of Legal Research Attorney. Under general dir...
We are seeking an attorney with a minimum of four years of experience in transactional work to join our well-established, nationally renowne...
The Insurance Adjustment Bureau, Inc., Plymouth Meeting, PA, a respected industry leader seeks an attorney with a minimum of 3-7 years exper...
